-
In this issue: New treatment for prostate cancer; avastin and breast cancer; new CMS disclosure rule; and FDA actions.
-
It might sound obvious to a reproductive medicine specialist to say that "every cell has a sex." On the other hand, even an obstetrician-gynecologist might be surprised to know how much of a contribution sex differences make to health and disease.
-
-
To investigate whether gonadal hormones influence cognitive function in postmenopausal women, the authors administered a comprehensive battery of neuropsychological tests on two occasions (2 years apart) to participants enrolled in the population-based, longitudinal Melbourne Women's Midlife Health Project.
-
In this issue: New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions.
-
-
Dealing with cytomegalovirus (CMV) can be vexing for everybody involved, but a recent paper may help with the management and counseling of patients infected with this virus at different times before and during pregnancy. Feldman et al studied 580 pregnant patients who were diagnosed with seriologic evidence of CMV infection.
-
The investigators performed a pooled analysis of individual data from two large studies by the International Agency for Research on Cancer (IARC) and Institut Català d'Oncologia (ICO) research program on human papillomavirus (HPV) and cervical cancer.
-
Hot flashes occur as a common consequence of breast cancer therapy and are quite debilitating for some.
-
In the initial phase of data collection, the authors identified two vaginal cuff dehiscences out of 665 total laparoscopic hysterectomies with transvaginal cuff closure (0.3%).